Equivalence of entropy balancing and the method of moments for matching-adjusted indirect comparison

被引:16
|
作者
Phillippo, David M. [1 ]
Dias, Sofia [1 ,2 ]
Ades, A. E. [1 ]
Welton, Nicky J. [1 ]
机构
[1] Univ Bristol, Bristol Med Sch Populat Hlth Sci, Canynge Hall,39 Whatley Rd, Bristol BS8 2PS, Avon, England
[2] Univ York, Ctr Reviews & Disseminat, York, N Yorkshire, England
基金
英国医学研究理事会;
关键词
effect modification; indirect comparison; individual patient data; matching-adjusted indirect comparison; population adjustment;
D O I
10.1002/jrsm.1416
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Indirect comparisons are used to obtain estimates of relative effectiveness between two treatments that have not been compared in the same randomized controlled trial, but have instead been compared against a common comparator in separate trials. Standard indirect comparisons use only aggregate data, under the assumption that there are no differences in effect-modifying variables between the trial populations. Population-adjusted indirect comparisons aim to relax this assumption by using individual patient data (IPD) from one trial to adjust for differences in effect modifiers between populations. At present, the most commonly used approach is matching-adjusted indirect comparison (MAIC), where weights are estimated that match the covariate distributions of the reweighted IPD to the aggregate trial. MAIC was originally proposed using the method of moments to estimate the weights, but more recently entropy balancing has been proposed as an alternative. Entropy balancing has an additional "optimality" property ensuring that the weights are as uniform as possible, reducing the standard error of the estimates. In this brief method note, we show that MAIC weights are mathematically identical whether estimated using entropy balancing or the method of moments. Importantly, this means that the standard MAIC (based on the method of moments) also enjoys the "optimality" property. Moreover, the additional flexibility of entropy balancing suggests several interesting avenues for further research, such as combining population adjustment via MAIC with adjustments for treatment switching or nonparametric covariate adjustment.
引用
收藏
页码:568 / 572
页数:5
相关论文
共 50 条
  • [21] A Critical Appraisal of Matching-Adjusted Indirect Comparisons in Spinal Muscular Atrophy
    Jiang, Tammy
    Youn, Bora
    Paradis, Angela D.
    Beckerman, Rachel
    Barnieh, Lianne
    Johnson, Nicole B.
    ADVANCES IN THERAPY, 2023, 40 (07) : 2985 - 3005
  • [22] Matching-adjusted indirect comparison: secukinumab versus infliximab in biologic-naive patients with psoriatic arthritis
    Strand, Vibeke
    McInnes, Iain
    Mease, Philip
    Nash, Peter
    Thom, Howard
    Kalyvas, Chrysostomos
    Hunger, Matthias
    Gandhi, Kunal
    Pricop, Luminita
    Jugl, Steffen
    Choy, Ernest
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2019, 8 (07) : 497 - 510
  • [23] Matching-Adjusted Indirect Comparison of Risankizumab Versus Deucravacitinib in Patients with Moderate-to-Severe Plaque Psoriasis
    Armstrong, April W.
    Soliman, Ahmed M.
    Gisondi, Paolo
    Fang, Siran
    Patel, Manish
    Strober, Bruce
    DERMATOLOGY AND THERAPY, 2024, 14 (11) : 3071 - 3081
  • [24] A Matching-Adjusted Indirect Comparison of Upadacitinib Versus Tofacitinib in Adults with Moderate-to-Severe Rheumatoid Arthritis
    Edwards, Christopher J.
    Sawant, Ruta
    Garg, Vishvas
    Du, Ella X.
    Friedman, Alan
    Betts, Keith A.
    RHEUMATOLOGY AND THERAPY, 2021, 8 (01) : 167 - 181
  • [25] A Matching-Adjusted Indirect Comparison of Upadacitinib Versus Tofacitinib in Adults with Moderate-to-Severe Rheumatoid Arthritis
    Christopher J. Edwards
    Ruta Sawant
    Vishvas Garg
    Ella X. Du
    Alan Friedman
    Keith A. Betts
    Rheumatology and Therapy, 2021, 8 : 167 - 181
  • [26] Matching-Adjusted Indirect Comparison of the 52-Week Efficacy of Bimekizumab Versus Secukinumab and Ixekizumab for the Treatment of Radiographic Axial Spondyloarthritis
    Maksymowych, Walter P.
    Thom, Howard
    Morup, Michael F.
    Taieb, Vanessa
    Willems, Damon
    Lyris, Nikos
    Gaffney, Karl
    RHEUMATOLOGY AND THERAPY, 2024, 11 (04) : 1023 - 1041
  • [27] Daclatasvir plus sofosbuvir versus standard of care for hepatitis C genotype 3: a matching-adjusted indirect comparison
    Swallow, Elyse
    Song, Jinlin
    Yuan, Yong
    Kalsekar, Anupama
    Kelley, Caroline
    Mu, Fan
    Kim, Soomi
    Noviello, Stephanie
    Signorovitch, James
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2016, 5 (02) : 129 - 139
  • [28] Matching-adjusted indirect comparison (MAIC) results confirmed by head-to-head trials: a case study in psoriasis
    Signorovitch, James
    Diels, Joris
    Van Sanden, Suzy
    Schubert, Agata
    Hassan, Fareen
    Thilakarathne, Pushpike
    Ozturk, Bulent
    Barthelmes, Norma
    Reich, Kristian
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2023, 34 (01)
  • [29] Matching-Adjusted Indirect Comparison (MAIC): Entrectinib versus Crizotinib in Asian Patients with ROS1+NSCLC
    Lu, S.
    Fan, Y.
    Yu, Y.
    Dong, X.
    Li, J.
    Zhao, J.
    Tao, S.
    Chen, M.
    Chen, Y.
    Liu, Y.
    Xu, J.
    Hu, X.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S679 - S679
  • [30] Relative effectiveness of sunitinib versus everolimus in advanced pancreatic neuroendocrine tumors: an updated matching-adjusted indirect comparison
    Ishak, K. Jack
    Rael, Michael
    Hicks, Meagen
    Mittal, Sangeeta
    Eatock, Martin
    Valle, Juan W.
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2018, 7 (10) : 947 - 958